The cold constricts small blood vessels, reducing the chances of bleeding
Muscle preservation during GLP-1 or medical weight-loss treatment depends heavily on protein intake, resistance training, adequate nutrition, dose management, sleep, hormones, and medical monitoring
HEK-Blue GLP-1 cells strongly respond to the incretin GLP-1 (7-36) amide, but not to other G protein-coupled receptor (GPCR)-activating peptide hormones, such as GIP (glucose-dependent insulinotropic polypeptide) or glucagon
These findings show that GLP-1 agonists can be game changers in improving blood glucose control and body weight and in reducing risk of cardiovascular events and death
Effects of Glucagon-Like Peptide-1 Receptor Agonists Liraglutide and Semaglutide on Cardiovascular and Renal Outcomes Across Body Mass Index Categories in Type 2 Diabetes: Results of the LEADER and SUSTAIN 6 Trials
Can athletes use GLP-1 drugs